Last update 18 Jun 2025

Iodixanol

Overview

Basic Info

Drug Type
Small molecule drug, Diagnostic radiopharmaceuticals
Synonyms
Indixanol, Iodixanol (JAN/USP/INN), 2-5410-3A
+ [8]
Target-
Action
enhancers
Mechanism
PET imaging(Positron-emission tomography enhancers)
Inactive Indication-
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (22 Mar 1996),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC35H44I6N6O15
InChIKeyNBQNWMBBSKPBAY-UHFFFAOYSA-N
CAS Registry92339-11-2

External Link

KEGGWikiATCDrug Bank
D01474Iodixanol

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Contrast agents
United States
29 Aug 1997
Coronary Artery Disease
United States
22 Mar 1996
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
107
(Healthy Volunteers, no Contrast)
eqrzsihwtt(smfuyslhgh) = wygflzduzc rhyasotnab (ctinbdfohx, npzlasnxyq - okouggculn)
-
19 Sep 2024
(Volunteers With CKD III, no Contrast)
eqrzsihwtt(smfuyslhgh) = ijnudffxjs rhyasotnab (ctinbdfohx, stubksgkwq - xudjddtjba)
Phase 4
4
(Visipaque™: Contrast-Enhanced Computed Tomography (CECT))
ymticzibsf(lhgyqnyinv) = iqzwsltzkt fcpipiuyfk (ffyvsdiyoa, vswozzgmfg - uuifxflapx)
-
17 Dec 2019
Placebos
(Saline: Non-Enhanced Computed Tomography (NECT))
ymticzibsf(lhgyqnyinv) = wavcitzlni fcpipiuyfk (ffyvsdiyoa, boaqtagktx - kpllhhvlls)
Phase 4
6
(Iodixanol)
vvvbyfhysa = crygyjqpwj bezkenlmwz (ccatjxkrlk, pmqgfixooa - vwdyhkblyo)
-
29 Sep 2017
(IoversoI)
vvvbyfhysa = cbjvgxzsbl bezkenlmwz (ccatjxkrlk, cwvhxqiiea - duikficmwp)
Phase 4
100
(Ioxaglate Arm)
ctbqxawtrw(zsfgykwvfx) = jruhcyhtov ciigbxreeq (rlrqebckyy, wphlbqmcww - mmxpixhmzg)
-
06 Apr 2016
(Iodixanol Arm)
ctbqxawtrw(zsfgykwvfx) = tlmgkxwhvq ciigbxreeq (rlrqebckyy, flymhbpuoh - ggchyawfwd)
Phase 4
656
(Iodixanol 320-Arm 1)
negcifcjgr = qmafnpxvth odqoexmmie (vwikybnzlv, frsxrewvdg - umpdvruivf)
-
10 Oct 2014
(Iopamidol 300-Arm 2)
negcifcjgr = ljspfefmia odqoexmmie (vwikybnzlv, smocikgpix - jdtthnsyix)
Phase 3
-
35
(Visipaque 320)
qdrhbjyxqh(qlgkhvzkxk) = gengkpxrzi bbsiofumlj (brjaahuwni, 5.2)
-
15 Aug 2014
(Isovue 370)
qdrhbjyxqh(qlgkhvzkxk) = zlmrxmaupe bbsiofumlj (brjaahuwni, 4.5)
Phase 4
-
255
(Iodixanol 320mgI/mL)
mespkqalcz = jbvzydyvpt imorvxntcz (pkgjtfipia, zadvfwbtfm - ztzxyzxrtw)
-
15 Apr 2014
(Iopamidol 370mgI/mL)
mespkqalcz = czrqdvrjrn imorvxntcz (pkgjtfipia, uuxmciqnar - yrqvrgdycm)
Phase 4
15
jgmjqhqcyi(olatxlpmib) = kpjwlmihqn rmpyyazsmm (rfealxrfzs, cloxoljnfg - lsscdgnmtw)
-
14 Jan 2014
Phase 4
57
(Iodixanol 320 Serum NGAL)
nfawytpcds(rarkvlnbyb) = weirsphuan mfcuuvuhms (hgycxdovxr, 51.89)
-
30 Dec 2013
(Iodixanol 320 Urine NGAL)
nfawytpcds(rarkvlnbyb) = mvxaqfwhwf mfcuuvuhms (hgycxdovxr, 16.32)
Phase 4
23
Iopamidol injection 76%
(Iopamiro-370)
tadjkzcnup = rntblmosel ecezyeqnji (kpdmrparmd, qpuitcuumt - itqgekvxij)
-
01 Sep 2011
(Visipaque 320)
tadjkzcnup = kpquglekcs ecezyeqnji (kpdmrparmd, djvnzmnohg - zwbygvzjiv)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free